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INTRODUCTION

Upper gastrointestinal (GI) bleeding is a common diagnosis with annual incidence
of hospitalization reported as 100 per 100,000 individuals and etiologies are
many. The most common causes are generally recognized to be esophageal
varices or peptic ulcer disease. Neoplasm in the stomach is a less common
cause, and is usually due to primary gastric adenocarcinoma. The gastrointestinal
tract can also be a site of metastases, however malignant melanoma is a
relatively rare cause of upper gastrointestinal bleeding, accounting for less than
3% of all severe cases of bleeding.

CASE REPORT

The patient is a 76-year-old male with a history of coronary artery disease
status post drug-eluting stent, ischemic cardiomyopathy, hyperlipidemia and
melanoma of the face treated thirty years prior, who presented to the emergency
department (ED) with hematemesis and melena for 2-3 days prior to admission
along with progressively worsening dyspnea on exertion and fatigue. The
patient had recently started aspirin and clopidogrel following drug eluting stent
placement. Upon evaluation in the ED, the patient was found to have blood
pressure 119/78, heart rate 98, respiration rate 18, oxygen saturation 97% on
2 liters via nasal cannula. A physical exam revealed pallor with poor capillary
refill. There was no abdominal tenderness. Lab work revealed hemoglobin 5.6,
white blood cells 13.3, serum creatinine 1.35, troponin 0.26
0.37. In the
ED, the patient was given two units of packed red blood cells (pRBC) and intravenous fluids for volume resuscitation and repeat blood work showed a hemoglobin of 7.6. The patient was evaluated by gastroenterology who recommended
esophagogastroduodenoscopy (EGD). The patient was admitted to low level
monitoring for continued blood transfusion requirement.
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RESULTS

The patient was initially managed with volume resuscitation
using crystalloids and blood products. EGD showed large
gastric ulcer with heaped margins along the greater curvature
of the stomach with a red the center. An endo clip was placed
for hemostasis. Biopsies were obtained which later revealed to be
metastatic malignant melanoma with S100 and MART1
positivity. Next-generation sequencing was performed
demonstrating negativity for BRAF, NRAS, and KIT mutations.
Computed tomography of the head showed an enhancing
spherical lesion in the right basal ganglia concerning for
metastatic disease.

Stomach cold forceps biopsy

CONCLUSION

Patients with metastatic melanoma to the GI tract have an
overall poor prognosis with life expectancy as short as four
months. With the rising incidence of melanoma and its
subsequent GI metastasis, it is important to recognize
metastatic disease early and potentially decrease the chance
of life-threatening complications, which may lead to an early
death. Only approximately 4% of patients with gastrointestinal
melanoma are diagnosed prior to death. Prophylactic evaluation
with endoscopy may be a powerful detection technique in
patients diagnosed with melanoma and could detect early
disease and provide treatment options to patients.
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